Skip to main content

ꯅꯍꯥꯛꯅꯥ ꯏꯄꯤꯂꯤꯃꯨꯃꯕ ꯄ꯭ꯔꯦꯁ꯭ꯛꯔꯥꯏꯕ ꯇꯧꯈ꯭ꯔꯕꯔꯥ? ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯁꯨꯞꯅꯇꯒꯤ ꯋꯥꯔꯤ ꯁꯥꯁꯤ (Ipilimumab Injection)

ꯅꯍꯥꯛꯅꯥ ꯏꯄꯤꯂꯤꯃꯨꯃꯕ ꯄ꯭ꯔꯦꯁ꯭ꯛꯔꯥꯏꯕ ꯇꯧꯈ꯭ꯔꯕꯔꯥ? ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯁꯨꯞꯅꯇꯒꯤ ꯋꯥꯔꯤ ꯁꯥꯁꯤ (Ipilimumab Injection)

ꯑꯩꯈꯣꯌ ꯄꯨꯝꯅꯃꯛꯅꯥ ꯈꯉꯏ ꯃꯗꯨꯗꯤ ꯀꯦꯟꯁꯔ ꯊꯦꯡꯅꯕꯥ ꯑꯁꯤ ꯏꯆꯝ ꯆꯝꯕꯥ ꯈꯣꯡꯆꯠ ꯅꯠꯇꯦ꯫ ꯈꯣꯡꯆꯠ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯗꯣꯛꯇꯔꯅꯥ ꯑꯗꯣꯃꯗꯥ ꯅꯠꯠꯔꯒꯥ ꯑꯗꯣꯃꯒꯤ ꯏꯃꯨꯡꯒꯤ ꯃꯤꯑꯣꯏ ꯑꯃꯗꯥ ‘ꯏꯄꯤꯂꯤꯃꯨꯃꯕ’ ꯀꯧꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯍꯥꯌꯕꯤꯔꯝꯂꯕꯔꯥ? ꯃꯤꯡ ꯑꯁꯤ ꯇꯥꯕꯗꯥ ꯈꯔꯥ ꯋꯥꯅꯥ ꯊꯣꯀꯄꯥ ꯌꯥꯏ, ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯅꯥ ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯐꯥꯎꯕꯥ ꯐꯥꯎꯕꯥ ꯌꯥꯏ꯫ ꯑꯗꯨꯕꯨ ꯋꯥꯈꯜ ꯋꯥꯕꯥ ꯂꯩꯔꯣꯏꯗꯕꯅꯤ꯫ ꯉꯁꯤ ꯑꯩꯈꯣꯌꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ, ꯃꯁꯤꯅꯥ ꯀꯔꯤ ꯇꯧꯔꯤꯕꯒꯦ, ꯑꯃꯁꯨꯡ ꯑꯗꯣꯝꯅꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯥ ꯊꯕꯀꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ, ꯌꯥꯝꯅꯥ ꯏꯆꯝ ꯆꯝꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯔꯨꯞ-ꯃꯄꯥꯡ ꯑꯣꯏꯕꯥ ꯃꯑꯣꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯒꯅꯤ꯫

ꯏꯄꯤꯂꯤꯃꯨꯃꯕ (YERVOY) ꯍꯥꯌꯕꯁꯤ ꯀꯔꯝꯕꯥ ꯃꯈꯂꯒꯤ ꯍꯤꯗꯥꯛꯅꯣ?

ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ ꯏꯄꯤꯂꯤꯃꯨꯃꯕ ꯑꯁꯤ ꯏꯝꯝꯌꯨꯅꯣꯊꯦꯔꯥꯄꯤ ꯑꯃꯅꯤ . ꯃꯁꯤ ꯇ꯭ꯔꯦꯗꯤꯁ꯭ꯅꯦꯜ ꯀꯦꯃꯣꯊꯦꯔꯥꯄꯤꯒꯨꯝꯅꯥ ꯅꯠꯇꯦ꯫ ꯃꯁꯤꯅꯥ ꯑꯩꯈꯣꯌꯒꯤ ꯏꯁꯥꯒꯤ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯝ ꯑꯁꯤꯕꯨ ꯊꯧꯒꯠꯇꯨꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯂꯁꯤꯡꯕꯨ ꯈꯉꯗꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯑꯦꯇꯦꯛ ꯇꯧꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯗꯨꯅꯥ ꯊꯕꯛ ꯇꯧꯏ꯫ ꯍꯦꯟꯅꯥ ꯑꯀꯛꯅꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ, ꯃꯁꯤ ꯑꯈꯟꯅꯅꯥ ꯗꯤꯖꯥꯏꯟ ꯇꯧꯕꯥ ꯄ꯭ꯔꯣꯇꯤꯟ ꯑꯃꯅꯤ꯫ ꯃꯦꯗꯤꯁꯤꯅꯗꯥ ꯑꯩꯈꯣꯌꯅꯥ ꯃꯁꯤꯕꯨ `ꯃꯣꯅꯣꯛꯂꯣꯅꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤ' ꯍꯥꯌꯅꯥ ꯀꯧꯏ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯇꯣꯉꯥꯟ-ꯇꯣꯉꯥꯅꯕꯥ ꯃꯈꯂꯒꯤ ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯩ꯫ ꯈꯨꯗꯝ ꯑꯣꯏꯅ:

  • ꯀꯣꯂꯣꯔꯦꯛꯇꯜ ꯀꯦꯟꯁꯔ꯫
  • ꯏꯁꯣꯐꯦꯖꯤꯌꯜ ꯀꯦꯟꯁꯔ꯫
  • ꯀꯤꯗꯅꯤꯒꯤ ꯀꯦꯟꯁꯔ꯫
  • ꯂꯤꯚꯔ ꯀꯦꯟꯁꯔ꯫
  • ꯂꯪꯁꯀꯤ ꯀꯦꯟꯁꯔ꯫
  • ꯃꯦꯂꯥꯅꯣꯃꯥ, ꯁ꯭ꯀꯤꯟ ꯀꯦꯟꯁꯔꯒꯤ ꯑꯀꯅꯕꯥ ꯃꯈꯜ ꯑꯃꯅꯤ꯫
  • ꯂꯪꯁꯀꯤ ꯂꯥꯏꯅꯤꯡꯒꯤ ꯀꯦꯟꯁꯔ (Mesothelioma) .

ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯑꯇꯩ ꯃꯦꯗꯤꯀꯦꯜ ꯀꯟꯗꯤꯁꯅꯁꯤꯡꯒꯤꯗꯃꯛꯇꯁꯨ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯔꯤꯀꯃꯦꯟꯗ ꯇꯧꯕꯥ ꯌꯥꯏ꯫

ꯂꯥꯏꯌꯦꯡ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯂꯥꯏꯌꯦꯡ ꯑꯁꯤ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯒꯤ ꯃꯃꯥꯡꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯃꯄꯨꯡꯐꯥꯕꯥ ꯍꯀꯁꯦꯂꯒꯤ ꯍꯤꯁ꯭ꯇꯔꯤ ꯑꯗꯨ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯈꯥꯗꯥ ꯄꯤꯔꯤꯕꯥ ꯀꯟꯗꯤꯁꯅꯁꯤꯡ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯑꯃꯍꯦꯛꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯃꯈꯣꯌꯗꯥ ꯁꯣꯌꯗꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ:

  • ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯣꯇꯣꯏꯝꯌꯨꯟ ꯂꯥꯌꯅꯥꯁꯤꯡ, ꯈꯨꯗꯝ ꯑꯣꯏꯅꯥ ꯀ꯭ꯔꯣꯅꯤꯛ ꯂꯥꯌꯅꯥ, ꯑꯂꯁꯦꯔꯦꯇꯤꯚ ꯀꯣꯂꯥꯏꯇꯤꯁ ꯅꯠꯠꯔꯒꯥ ꯂꯨꯄꯁ ꯂꯩꯔꯕꯗꯤ, ꯃꯗꯨꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯏꯁꯥꯒꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯁꯔꯨꯀꯁꯤꯡꯗꯥ ꯑꯁꯣꯌꯕꯥ ꯂꯩꯍꯟꯗꯅꯥ ꯑꯦꯇꯦꯛ ꯇꯧꯏ꯫
  • ꯑꯣꯔꯒꯥꯟ ꯇ꯭ꯔꯥꯟꯁꯞꯂꯥꯟꯇꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯃꯥꯡꯗꯥ ꯑꯣꯔꯒꯥꯟ ꯇ꯭ꯔꯥꯟꯁꯞꯂꯥꯟꯇ ꯇꯧꯈ꯭ꯔꯕꯗꯤ꯫
  • ꯁ꯭ꯇꯦꯝ ꯁꯦꯜ ꯇ꯭ꯔꯥꯟꯁꯞꯂꯥꯟꯇꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯇꯣꯞꯄꯥ ꯃꯤꯑꯣꯏ ꯑꯃꯗꯒꯤ ꯑꯦꯂꯣꯖꯦꯅꯤꯛ ꯁ꯭ꯇꯦꯝ ꯁꯦꯜ ꯇ꯭ꯔꯥꯟꯁꯞꯂꯥꯟꯇ ꯑꯃꯥ ꯇꯧꯈ꯭ꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯄꯥꯡꯊꯣꯛꯅꯕꯥ ꯊꯧꯔꯥꯡ ꯇꯧꯔꯕꯗꯤ꯫
  • ꯅꯔꯚ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ `ꯃꯥꯏꯁ꯭ꯇꯦꯅꯤꯌꯥ ꯒ꯭ꯔꯦꯚꯤꯁ` ꯅꯠꯠꯔꯒꯥ `ꯒꯨꯏꯂꯦꯟ-ꯕꯥꯔꯦ ꯁꯤꯟꯗꯣꯝ`ꯒꯨꯝꯕꯥ ꯅꯔꯚ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯑꯦꯂꯥꯔꯖꯤ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ (Ipilimumab) ꯅꯠꯠꯔꯒꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ, ꯆꯤꯟꯖꯥꯛ, ꯅꯠꯠꯔꯒꯥ ꯗꯥꯏꯑꯦꯠ ꯑꯃꯍꯦꯛꯇꯒꯤ ꯑꯦꯂꯥꯔꯖꯤ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯤꯔꯣꯅꯕꯥ ꯑꯣꯏꯔꯕꯗꯤ, ꯃꯤꯔꯣꯅꯕꯥ ꯍꯣꯠꯅꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯆꯤꯡꯅꯕꯥ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛ ꯑꯁꯤ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯃꯃꯥ ꯑꯃꯥ ꯑꯣꯏꯔꯕꯗꯤ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯃꯃꯥ ꯑꯃꯥ ꯑꯣꯏꯔꯕꯗꯤ꯫

ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯑꯁꯤ ꯂꯣꯠꯁꯤꯟꯗꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯅꯍꯥꯛꯀꯤ ꯁꯦꯐꯇꯤ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯂꯥꯏꯌꯦꯡꯒꯤ ꯃꯥꯌꯄꯥꯀꯄꯒꯤꯗꯃꯛ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯀꯔꯝꯅꯥ ꯄꯤꯕꯒꯦ?

ꯃꯁꯤ ꯅꯍꯥꯛꯅꯥ ꯌꯨꯃꯗꯥ ꯄꯨꯔꯀꯄꯥ ꯍꯤꯗꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯀꯦꯄꯆꯔ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯁꯦꯂꯥꯏꯅꯒꯨꯝꯕꯥ ꯚꯦꯅꯝ ꯑꯃꯗꯥ ꯄꯤꯕꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯃꯅꯤ꯫ ꯃꯁꯤꯒꯤ ꯂꯥꯏꯌꯦꯡ ꯑꯁꯤ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯅꯠꯠꯔꯒꯥ ꯀ꯭ꯂꯤꯅꯤꯛ ꯑꯃꯗꯥ, ꯗꯣꯛꯇꯔ ꯅꯠꯠꯔꯒꯥ ꯇ꯭ꯔꯦꯟ ꯇꯧꯔꯕꯥ ꯅꯔꯁꯤꯡ ꯁ꯭ꯇꯥꯐ ꯑꯃꯒꯤ ꯃꯄꯨꯡꯐꯥꯕꯥ ꯌꯦꯡꯁꯤꯅꯕꯒꯤ ꯃꯈꯥꯗꯥ ꯄꯤ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯃꯤꯅꯠ 30ꯗꯒꯤ 90 ꯐꯥꯎꯕꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯍꯀꯆꯥꯡꯗꯥ ꯄꯤ꯫ ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯁꯦꯁꯟ ꯈꯨꯗꯤꯡꯒꯤ ꯃꯃꯥꯡꯗꯥ, ꯅꯍꯥꯀꯄꯨ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯑꯈꯟꯅꯕꯥ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯂꯤꯐꯂꯦꯠ (MedGuide) ꯑꯃꯥ ꯄꯤꯒꯅꯤ꯫ ꯃꯇꯝ ꯈꯨꯗꯤꯡꯗꯥ ꯃꯁꯤꯕꯨ ꯅꯤꯡꯊꯤꯅꯥ ꯄꯥꯕꯥ ꯑꯃꯁꯨꯡ ꯂꯧꯁꯤꯅꯕꯥ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯗꯣꯖ ꯑꯃꯥ ꯃꯥꯡꯈꯤꯕꯥ ꯑꯁꯤ ꯑꯆꯧꯕꯥ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯝ ꯑꯃꯥ ꯑꯣꯏꯕꯥ ꯌꯥꯏ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯁꯦꯗ꯭ꯌꯨꯜ ꯇꯧꯔꯕꯥ ꯑꯦꯄꯣꯏꯟꯇꯃꯦꯟꯇ ꯑꯗꯨꯗꯥ ꯆꯠꯄꯥ ꯉꯃꯗ꯭ꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔ ꯅꯠꯠꯔꯒꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯐꯣꯟ ꯇꯧꯗꯨꯅꯥ ꯃꯈꯣꯌꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ ꯑꯃꯁꯨꯡ ꯃꯊꯪꯗꯥ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ ꯍꯥꯌꯕꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯤꯌꯨ꯫

ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯃꯇꯃꯗꯥ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

  • ꯃꯤꯔꯣꯜꯂꯤꯉꯩ ꯑꯃꯁꯨꯡ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ: ꯃꯁꯤꯅꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯋꯥꯐꯃꯅꯤ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯆꯥꯔꯤꯉꯩꯗꯥ ꯑꯃꯁꯨꯡ ꯂꯥꯏꯌꯦꯡ ꯂꯦꯄꯈ꯭ꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯊꯥ 3 ꯐꯥꯎꯕꯥ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯃꯤꯔꯣꯅꯕꯥ ꯊꯤꯡꯖꯤꯜꯂꯨ꯫ ꯃꯁꯤꯅꯥ ꯄꯣꯀꯄꯥ ꯑꯉꯥꯡ ꯑꯃꯗꯥ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯅꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯃꯁꯤꯗꯁꯨ ꯅꯠꯇꯅꯥ, ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯃꯇꯃꯗꯥ ꯑꯃꯁꯨꯡ ꯑꯔꯣꯏꯕꯥ ꯗꯣꯖꯒꯤ ꯃꯇꯨꯡꯗꯥ ꯊꯥ 3 ꯐꯥꯎꯕꯥ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯌꯥꯔꯣꯏꯗꯕꯅꯤ꯫
  • ꯃꯦꯗꯤꯀꯦꯜ ꯁꯨꯄꯔꯚꯤꯖꯟ: ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯂꯥꯏꯌꯦꯡ ꯄꯨꯝꯅꯃꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯀꯟꯗꯤꯁꯟ ꯑꯗꯨ ꯅꯤꯡꯊꯤꯅꯥ ꯌꯦꯡꯁꯤꯅꯒꯅꯤ, ꯃꯁꯤꯗꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯕ꯭ꯂꯗ ꯇꯦꯁ꯭ꯠ ꯇꯧꯅꯕꯥ ꯑꯣꯔꯗꯔ ꯇꯧꯕꯥ (ꯕ꯭ꯂꯗ ꯋꯥꯔꯛ) ꯌꯥꯎꯏ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯣꯚꯔꯗꯣꯖ ꯇꯧꯔꯕꯗꯤ: ꯃꯁꯤ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯄꯤꯕꯅꯥ ꯃꯔꯝ ꯑꯣꯏꯗꯨꯅꯥ ꯌꯥꯝꯅꯥ ꯇꯣꯏꯅꯥ ꯊꯣꯀꯄꯥ ꯌꯥꯏ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯣꯚꯔꯗꯣꯖ ꯇꯧꯔꯦ ꯍꯥꯌꯅꯥ ꯆꯤꯡꯅꯕꯥ ꯂꯩꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯀꯟꯇꯦꯛꯇ ꯇꯧꯕꯤꯌꯨ ꯅꯠꯠꯔꯒꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯅꯀꯄꯥ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯗꯤꯄꯥꯔꯇꯃꯦꯟꯇ (ETU) ꯗꯥ ꯆꯠꯄꯤꯌꯨ꯫

ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ꯫

ꯍꯤꯗꯥꯛ ꯑꯃꯍꯦꯛꯇꯒꯨꯝꯅꯥ ꯏꯄꯤꯂꯤꯃꯨꯃꯕꯅꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯈꯔꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯃꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯈꯔꯗꯤ ꯈꯨꯗꯛꯇꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯒꯗꯕꯅꯤ, ꯑꯗꯨꯒꯥ ꯑꯇꯩ ꯈꯔꯗꯤ ꯑꯁꯨꯛ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯣꯏꯗꯦ꯫ ꯃꯈꯥꯒꯤ ꯇꯦꯕꯜ ꯑꯁꯤꯗꯒꯤ ꯃꯁꯤ ꯃꯌꯦꯛ ꯁꯦꯡꯅꯥ ꯈꯉꯁꯤ꯫

ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ꯫ ꯃꯁꯛ ꯈꯪꯗꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫
ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯍꯥꯌꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫
ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯅꯁꯤꯡ꯫ ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯥꯌ, ꯊꯕꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ, ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ꯫
ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯗꯥꯏꯔꯤꯌꯥ ꯂꯩꯕꯥ꯫ ꯁꯥꯊꯤꯅꯥ ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯂꯨꯝꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯏ ꯊꯣꯀꯄꯥ, ꯑꯃꯁꯨꯡ ꯕ꯭ꯂꯦꯛ, ꯇꯦꯔꯤ ꯁ꯭ꯇꯣꯂꯁꯤꯡ꯫
ꯂꯤꯚꯔꯗꯥ ꯑꯃꯥꯡ-ꯑꯇꯥ ꯊꯣꯀꯍꯅꯕꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫ ꯃꯤꯠ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯌꯦꯔꯨꯝ ꯀꯣꯀꯄꯥ, ꯃꯌꯦꯛ ꯁꯦꯡꯕꯥ ꯌꯦꯔꯨꯝ/ ꯕ꯭ꯔꯎꯟ ꯌꯨꯔꯤꯟ, ꯂꯦꯡ-ꯑꯣꯠꯄꯒꯤ ꯃꯑꯣꯡ-ꯃꯇꯧ, ꯈꯣꯡꯒꯤ ꯃꯊꯛ ꯊꯪꯕꯥ ꯁꯔꯨꯛꯇꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯄꯥ, ꯆꯥꯛ ꯆꯥꯕꯥ ꯋꯥꯠꯄꯥ, ꯋꯥꯈꯜ ꯆꯔꯥꯡꯅꯕꯥ, ꯌꯥꯝꯅꯥ ꯋꯥꯅꯥ ꯋꯥꯈꯜ ꯇꯥꯕꯥ꯫
ꯈꯣꯡꯒꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡ꯫ ꯈꯣꯡꯗꯥ ꯂꯥꯎꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ (ꯃꯤꯠꯀꯤ ꯃꯅꯨꯡꯗꯥ ꯐꯥꯎꯕꯥ)꯫
ꯅꯔꯚ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡ꯫ ꯃꯈꯨꯠ-ꯃꯁꯥꯗꯥ ꯁꯣꯟꯊꯕꯥ, ꯑꯅꯥꯕꯥ, ꯃꯤꯠ ꯎꯗꯕꯥ, ꯃꯤꯠ ꯎꯗꯕꯥ, ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯅꯥ ꯃꯤꯠ ꯎꯗꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯁꯥ ꯃꯊꯟꯇꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ꯫
ꯍꯥꯔꯠ ꯔꯦꯇꯇꯥ ꯑꯍꯣꯡꯕꯥ ꯂꯥꯀꯄꯥ꯫ ꯅꯍꯥꯛꯀꯤ ꯊꯝꯃꯣꯌꯅꯥ ꯌꯥꯡꯅꯥ ꯅꯠꯠꯔꯒꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯁꯣꯀꯄꯥ, ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯈꯣꯌꯅꯥ ꯂꯦꯞꯄꯥ ꯂꯩꯇꯅꯥ ꯅꯠꯠꯔꯒꯥ ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯐꯥꯎꯔꯕꯗꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯍꯥꯌꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫
ꯀꯣꯛ ꯆꯤꯛꯄ ꯖꯦꯅꯦꯔꯦꯜ ꯍꯦꯗ-ꯑꯦꯛ꯫
ꯆꯥꯅꯤꯡꯕ ꯊꯛꯅꯤꯡꯕ ꯐꯥꯎꯕ ꯆꯥꯛ ꯆꯥꯕꯥ ꯍꯟꯊꯔꯀꯄꯥ꯫
ꯇꯨꯝꯕ ꯌꯥꯗꯕꯑꯌꯨꯛꯇꯥ ꯇꯨꯝꯕꯥ ꯉꯃꯗꯕꯥ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯂꯤꯁ꯭ꯠ ꯑꯁꯤꯗꯥ ꯄꯅꯈ꯭ꯔꯤꯕꯥ ꯑꯇꯩ ꯑꯆꯝꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯂꯩꯔꯕꯗꯤ, ꯆꯥꯅꯕꯤꯗꯨꯅꯥ ꯃꯈꯣꯌꯒꯤ ꯃꯇꯥꯡꯗꯁꯨ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫

ꯇꯦꯛ-ꯍꯣꯝ ꯃꯦꯁꯦꯖ ꯇꯧꯕꯥ꯫

  • ꯏꯄꯤꯂꯤꯃꯨꯃꯕ ꯑꯁꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯃꯁꯥꯒꯤ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯂꯁꯤꯡꯗꯥ ꯑꯦꯇꯦꯛ ꯇꯧꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯂꯤꯕꯥ ꯑꯀꯛꯅꯕꯥ ꯂꯥꯌꯦꯡ ꯑꯃꯅꯤ꯫
  • ꯂꯥꯏꯌꯦꯡ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯃꯦꯗꯤꯀꯦꯜ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯁꯨꯡ ꯑꯦꯂꯥꯔꯖꯤ ꯄꯨꯝꯅꯃꯛꯀꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯑꯁꯤ ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯃꯇꯃꯗꯥ ꯑꯃꯁꯨꯡ ꯃꯗꯨ ꯂꯣꯌꯔꯕꯥ ꯃꯇꯨꯡ ꯊꯥ 3 ꯐꯥꯎꯕꯥ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯊꯤꯡꯖꯤꯜꯂꯨ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯗꯥꯏꯔꯤꯌꯥ, ꯁꯥꯊꯤꯕꯥ ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯤꯠ ꯎꯗꯕꯥ, ꯅꯠꯠꯔꯒꯥ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ ꯑꯁꯤꯅꯆꯤꯡꯕꯥ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯑꯃꯠꯇꯥ ꯂꯩꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
  • ꯁꯦꯗ꯭ꯌꯨꯜ ꯇꯧꯔꯕꯥ ꯂꯥꯏꯌꯦꯡꯒꯤ ꯑꯦꯄꯣꯏꯟꯇꯃꯦꯟꯇꯁꯤꯡ ꯑꯗꯨ ꯊꯥꯗꯣꯛꯂꯣꯏꯗꯕꯅꯤ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯔꯝ ꯑꯃꯍꯦꯛꯇꯗꯒꯤ ꯅꯍꯥꯛꯅꯥ ꯂꯥꯀꯄꯥ ꯉꯃꯗ꯭ꯔꯕꯗꯤ, ꯆꯥꯅꯕꯤꯗꯨꯅꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯍꯥꯟꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫

ꯏꯄꯤꯂꯤꯃꯨꯃꯕ, ꯌꯦꯔꯚꯣꯌ, ꯀꯦꯟꯁꯔ, ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡ, ꯃꯣꯅꯣꯛꯂꯣꯅꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤ, ꯏꯝꯝꯌꯨꯅꯣꯊꯦꯔꯥꯄꯤ, ꯀꯦꯟꯁꯔꯒꯤ ꯍꯤꯗꯥꯛ, ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ꯫
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No comments yet. Be the first to share your thoughts here.

Add Your Comment

Please calculate: 2 + 6 =
ꯅꯍꯥꯛꯅꯥ ꯏꯄꯤꯂꯤꯃꯨꯃꯕ ꯄ꯭ꯔꯦꯁ꯭ꯛꯔꯥꯏꯕ ꯇꯧꯈ꯭ꯔꯕꯔꯥ? ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯁꯨꯞꯅꯇꯒꯤ ꯋꯥꯔꯤ ꯁꯥꯁꯤ (Ipilimumab Injection)
ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ꯫জুলাই ৬, ২০২৬

ꯅꯍꯥꯛꯅꯥ ꯏꯄꯤꯂꯤꯃꯨꯃꯕ ꯄ꯭ꯔꯦꯁ꯭ꯛꯔꯥꯏꯕ ꯇꯧꯈ꯭ꯔꯕꯔꯥ? ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯁꯨꯞꯅꯇꯒꯤ ꯋꯥꯔꯤ ꯁꯥꯁꯤ (Ipilimumab Injection)

ꯑꯩꯈꯣꯌ ꯄꯨꯝꯅꯃꯛꯅꯥ ꯈꯉꯏ ꯃꯗꯨꯗꯤ ꯀꯦꯟꯁꯔ ꯊꯦꯡꯅꯕꯥ ꯑꯁꯤ ꯏꯆꯝ ꯆꯝꯕꯥ ꯈꯣꯡꯆꯠ ꯅꯠꯇꯦ꯫ ꯈꯣꯡꯆꯠ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯗꯣꯛꯇꯔꯅꯥ ꯑꯗꯣꯃꯗꯥ ꯅꯠꯠꯔꯒꯥ ꯑꯗꯣꯃꯒꯤ ꯏꯃꯨꯡꯒꯤ ꯃꯤꯑꯣꯏ ꯑꯃꯗꯥ ‘ꯏꯄꯤꯂꯤꯃꯨꯃꯕ’ ꯀꯧꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯍꯥꯌꯕꯤꯔꯝꯂꯕꯔꯥ? ꯃꯤꯡ ꯑꯁꯤ ꯇꯥꯕꯗꯥ ꯈꯔꯥ ꯋꯥꯅꯥ ꯊꯣꯀꯄꯥ ꯌꯥꯏ, ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯅꯥ ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯐꯥꯎꯕꯥ ꯐꯥꯎꯕꯥ ꯌꯥꯏ꯫ ꯑꯗꯨꯕꯨ ꯋꯥꯈꯜ ꯋꯥꯕꯥ ꯂꯩꯔꯣꯏꯗꯕꯅꯤ꯫ ꯉꯁꯤ ꯑꯩꯈꯣꯌꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ, ꯃꯁꯤꯅꯥ ꯀꯔꯤ ꯇꯧꯔꯤꯕꯒꯦ, ꯑꯃꯁꯨꯡ ꯑꯗꯣꯝꯅꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯥ ꯊꯕꯀꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ, ꯌꯥꯝꯅꯥ ꯏꯆꯝ ꯆꯝꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯔꯨꯞ-ꯃꯄꯥꯡ ꯑꯣꯏꯕꯥ ꯃꯑꯣꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯒꯅꯤ꯫

ꯏꯄꯤꯂꯤꯃꯨꯃꯕ (YERVOY) ꯍꯥꯌꯕꯁꯤ ꯀꯔꯝꯕꯥ ꯃꯈꯂꯒꯤ ꯍꯤꯗꯥꯛꯅꯣ?

ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ ꯏꯄꯤꯂꯤꯃꯨꯃꯕ ꯑꯁꯤ ꯏꯝꯝꯌꯨꯅꯣꯊꯦꯔꯥꯄꯤ ꯑꯃꯅꯤ . ꯃꯁꯤ ꯇ꯭ꯔꯦꯗꯤꯁ꯭ꯅꯦꯜ ꯀꯦꯃꯣꯊꯦꯔꯥꯄꯤꯒꯨꯝꯅꯥ ꯅꯠꯇꯦ꯫ ꯃꯁꯤꯅꯥ ꯑꯩꯈꯣꯌꯒꯤ ꯏꯁꯥꯒꯤ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯝ ꯑꯁꯤꯕꯨ ꯊꯧꯒꯠꯇꯨꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯂꯁꯤꯡꯕꯨ ꯈꯉꯗꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯑꯦꯇꯦꯛ ꯇꯧꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯗꯨꯅꯥ ꯊꯕꯛ ꯇꯧꯏ꯫ ꯍꯦꯟꯅꯥ ꯑꯀꯛꯅꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ, ꯃꯁꯤ ꯑꯈꯟꯅꯅꯥ ꯗꯤꯖꯥꯏꯟ ꯇꯧꯕꯥ ꯄ꯭ꯔꯣꯇꯤꯟ ꯑꯃꯅꯤ꯫ ꯃꯦꯗꯤꯁꯤꯅꯗꯥ ꯑꯩꯈꯣꯌꯅꯥ ꯃꯁꯤꯕꯨ `ꯃꯣꯅꯣꯛꯂꯣꯅꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤ' ꯍꯥꯌꯅꯥ ꯀꯧꯏ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯇꯣꯉꯥꯟ-ꯇꯣꯉꯥꯅꯕꯥ ꯃꯈꯂꯒꯤ ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯩ꯫ ꯈꯨꯗꯝ ꯑꯣꯏꯅ:

  • ꯀꯣꯂꯣꯔꯦꯛꯇꯜ ꯀꯦꯟꯁꯔ꯫
  • ꯏꯁꯣꯐꯦꯖꯤꯌꯜ ꯀꯦꯟꯁꯔ꯫
  • ꯀꯤꯗꯅꯤꯒꯤ ꯀꯦꯟꯁꯔ꯫
  • ꯂꯤꯚꯔ ꯀꯦꯟꯁꯔ꯫
  • ꯂꯪꯁꯀꯤ ꯀꯦꯟꯁꯔ꯫
  • ꯃꯦꯂꯥꯅꯣꯃꯥ, ꯁ꯭ꯀꯤꯟ ꯀꯦꯟꯁꯔꯒꯤ ꯑꯀꯅꯕꯥ ꯃꯈꯜ ꯑꯃꯅꯤ꯫
  • ꯂꯪꯁꯀꯤ ꯂꯥꯏꯅꯤꯡꯒꯤ ꯀꯦꯟꯁꯔ (Mesothelioma) .

ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯑꯇꯩ ꯃꯦꯗꯤꯀꯦꯜ ꯀꯟꯗꯤꯁꯅꯁꯤꯡꯒꯤꯗꯃꯛꯇꯁꯨ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯔꯤꯀꯃꯦꯟꯗ ꯇꯧꯕꯥ ꯌꯥꯏ꯫

ꯂꯥꯏꯌꯦꯡ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯂꯥꯏꯌꯦꯡ ꯑꯁꯤ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯒꯤ ꯃꯃꯥꯡꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯃꯄꯨꯡꯐꯥꯕꯥ ꯍꯀꯁꯦꯂꯒꯤ ꯍꯤꯁ꯭ꯇꯔꯤ ꯑꯗꯨ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯈꯥꯗꯥ ꯄꯤꯔꯤꯕꯥ ꯀꯟꯗꯤꯁꯅꯁꯤꯡ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯑꯃꯍꯦꯛꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯃꯈꯣꯌꯗꯥ ꯁꯣꯌꯗꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ:

  • ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯣꯇꯣꯏꯝꯌꯨꯟ ꯂꯥꯌꯅꯥꯁꯤꯡ, ꯈꯨꯗꯝ ꯑꯣꯏꯅꯥ ꯀ꯭ꯔꯣꯅꯤꯛ ꯂꯥꯌꯅꯥ, ꯑꯂꯁꯦꯔꯦꯇꯤꯚ ꯀꯣꯂꯥꯏꯇꯤꯁ ꯅꯠꯠꯔꯒꯥ ꯂꯨꯄꯁ ꯂꯩꯔꯕꯗꯤ, ꯃꯗꯨꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯏꯁꯥꯒꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯁꯔꯨꯀꯁꯤꯡꯗꯥ ꯑꯁꯣꯌꯕꯥ ꯂꯩꯍꯟꯗꯅꯥ ꯑꯦꯇꯦꯛ ꯇꯧꯏ꯫
  • ꯑꯣꯔꯒꯥꯟ ꯇ꯭ꯔꯥꯟꯁꯞꯂꯥꯟꯇꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯃꯥꯡꯗꯥ ꯑꯣꯔꯒꯥꯟ ꯇ꯭ꯔꯥꯟꯁꯞꯂꯥꯟꯇ ꯇꯧꯈ꯭ꯔꯕꯗꯤ꯫
  • ꯁ꯭ꯇꯦꯝ ꯁꯦꯜ ꯇ꯭ꯔꯥꯟꯁꯞꯂꯥꯟꯇꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯇꯣꯞꯄꯥ ꯃꯤꯑꯣꯏ ꯑꯃꯗꯒꯤ ꯑꯦꯂꯣꯖꯦꯅꯤꯛ ꯁ꯭ꯇꯦꯝ ꯁꯦꯜ ꯇ꯭ꯔꯥꯟꯁꯞꯂꯥꯟꯇ ꯑꯃꯥ ꯇꯧꯈ꯭ꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯄꯥꯡꯊꯣꯛꯅꯕꯥ ꯊꯧꯔꯥꯡ ꯇꯧꯔꯕꯗꯤ꯫
  • ꯅꯔꯚ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ `ꯃꯥꯏꯁ꯭ꯇꯦꯅꯤꯌꯥ ꯒ꯭ꯔꯦꯚꯤꯁ` ꯅꯠꯠꯔꯒꯥ `ꯒꯨꯏꯂꯦꯟ-ꯕꯥꯔꯦ ꯁꯤꯟꯗꯣꯝ`ꯒꯨꯝꯕꯥ ꯅꯔꯚ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯑꯦꯂꯥꯔꯖꯤ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ (Ipilimumab) ꯅꯠꯠꯔꯒꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ, ꯆꯤꯟꯖꯥꯛ, ꯅꯠꯠꯔꯒꯥ ꯗꯥꯏꯑꯦꯠ ꯑꯃꯍꯦꯛꯇꯒꯤ ꯑꯦꯂꯥꯔꯖꯤ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯤꯔꯣꯅꯕꯥ ꯑꯣꯏꯔꯕꯗꯤ, ꯃꯤꯔꯣꯅꯕꯥ ꯍꯣꯠꯅꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯆꯤꯡꯅꯕꯥ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛ ꯑꯁꯤ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯃꯃꯥ ꯑꯃꯥ ꯑꯣꯏꯔꯕꯗꯤ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯍꯥꯛꯀꯤ ꯑꯉꯥꯡ ꯑꯗꯨ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯃꯃꯥ ꯑꯃꯥ ꯑꯣꯏꯔꯕꯗꯤ꯫

ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯑꯁꯤ ꯂꯣꯠꯁꯤꯟꯗꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯅꯍꯥꯛꯀꯤ ꯁꯦꯐꯇꯤ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯂꯥꯏꯌꯦꯡꯒꯤ ꯃꯥꯌꯄꯥꯀꯄꯒꯤꯗꯃꯛ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯀꯔꯝꯅꯥ ꯄꯤꯕꯒꯦ?

ꯃꯁꯤ ꯅꯍꯥꯛꯅꯥ ꯌꯨꯃꯗꯥ ꯄꯨꯔꯀꯄꯥ ꯍꯤꯗꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯀꯦꯄꯆꯔ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯁꯦꯂꯥꯏꯅꯒꯨꯝꯕꯥ ꯚꯦꯅꯝ ꯑꯃꯗꯥ ꯄꯤꯕꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯃꯅꯤ꯫ ꯃꯁꯤꯒꯤ ꯂꯥꯏꯌꯦꯡ ꯑꯁꯤ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯅꯠꯠꯔꯒꯥ ꯀ꯭ꯂꯤꯅꯤꯛ ꯑꯃꯗꯥ, ꯗꯣꯛꯇꯔ ꯅꯠꯠꯔꯒꯥ ꯇ꯭ꯔꯦꯟ ꯇꯧꯔꯕꯥ ꯅꯔꯁꯤꯡ ꯁ꯭ꯇꯥꯐ ꯑꯃꯒꯤ ꯃꯄꯨꯡꯐꯥꯕꯥ ꯌꯦꯡꯁꯤꯅꯕꯒꯤ ꯃꯈꯥꯗꯥ ꯄꯤ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯍꯧꯁꯥꯅꯥ ꯃꯤꯅꯠ 30ꯗꯒꯤ 90 ꯐꯥꯎꯕꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯍꯀꯆꯥꯡꯗꯥ ꯄꯤ꯫ ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯁꯦꯁꯟ ꯈꯨꯗꯤꯡꯒꯤ ꯃꯃꯥꯡꯗꯥ, ꯅꯍꯥꯀꯄꯨ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯑꯈꯟꯅꯕꯥ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯂꯤꯐꯂꯦꯠ (MedGuide) ꯑꯃꯥ ꯄꯤꯒꯅꯤ꯫ ꯃꯇꯝ ꯈꯨꯗꯤꯡꯗꯥ ꯃꯁꯤꯕꯨ ꯅꯤꯡꯊꯤꯅꯥ ꯄꯥꯕꯥ ꯑꯃꯁꯨꯡ ꯂꯧꯁꯤꯅꯕꯥ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯗꯣꯖ ꯑꯃꯥ ꯃꯥꯡꯈꯤꯕꯥ ꯑꯁꯤ ꯑꯆꯧꯕꯥ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯝ ꯑꯃꯥ ꯑꯣꯏꯕꯥ ꯌꯥꯏ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯁꯦꯗ꯭ꯌꯨꯜ ꯇꯧꯔꯕꯥ ꯑꯦꯄꯣꯏꯟꯇꯃꯦꯟꯇ ꯑꯗꯨꯗꯥ ꯆꯠꯄꯥ ꯉꯃꯗ꯭ꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔ ꯅꯠꯠꯔꯒꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯐꯣꯟ ꯇꯧꯗꯨꯅꯥ ꯃꯈꯣꯌꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ ꯑꯃꯁꯨꯡ ꯃꯊꯪꯗꯥ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ ꯍꯥꯌꯕꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯤꯌꯨ꯫

ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯃꯇꯃꯗꯥ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

  • ꯃꯤꯔꯣꯜꯂꯤꯉꯩ ꯑꯃꯁꯨꯡ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ: ꯃꯁꯤꯅꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯋꯥꯐꯃꯅꯤ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯆꯥꯔꯤꯉꯩꯗꯥ ꯑꯃꯁꯨꯡ ꯂꯥꯏꯌꯦꯡ ꯂꯦꯄꯈ꯭ꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯊꯥ 3 ꯐꯥꯎꯕꯥ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯃꯤꯔꯣꯅꯕꯥ ꯊꯤꯡꯖꯤꯜꯂꯨ꯫ ꯃꯁꯤꯅꯥ ꯄꯣꯀꯄꯥ ꯑꯉꯥꯡ ꯑꯃꯗꯥ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯅꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯃꯁꯤꯗꯁꯨ ꯅꯠꯇꯅꯥ, ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯃꯇꯃꯗꯥ ꯑꯃꯁꯨꯡ ꯑꯔꯣꯏꯕꯥ ꯗꯣꯖꯒꯤ ꯃꯇꯨꯡꯗꯥ ꯊꯥ 3 ꯐꯥꯎꯕꯥ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯌꯥꯔꯣꯏꯗꯕꯅꯤ꯫
  • ꯃꯦꯗꯤꯀꯦꯜ ꯁꯨꯄꯔꯚꯤꯖꯟ: ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯂꯥꯏꯌꯦꯡ ꯄꯨꯝꯅꯃꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯀꯟꯗꯤꯁꯟ ꯑꯗꯨ ꯅꯤꯡꯊꯤꯅꯥ ꯌꯦꯡꯁꯤꯅꯒꯅꯤ, ꯃꯁꯤꯗꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯕ꯭ꯂꯗ ꯇꯦꯁ꯭ꯠ ꯇꯧꯅꯕꯥ ꯑꯣꯔꯗꯔ ꯇꯧꯕꯥ (ꯕ꯭ꯂꯗ ꯋꯥꯔꯛ) ꯌꯥꯎꯏ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯣꯚꯔꯗꯣꯖ ꯇꯧꯔꯕꯗꯤ: ꯃꯁꯤ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯄꯤꯕꯅꯥ ꯃꯔꯝ ꯑꯣꯏꯗꯨꯅꯥ ꯌꯥꯝꯅꯥ ꯇꯣꯏꯅꯥ ꯊꯣꯀꯄꯥ ꯌꯥꯏ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯣꯚꯔꯗꯣꯖ ꯇꯧꯔꯦ ꯍꯥꯌꯅꯥ ꯆꯤꯡꯅꯕꯥ ꯂꯩꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯀꯟꯇꯦꯛꯇ ꯇꯧꯕꯤꯌꯨ ꯅꯠꯠꯔꯒꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯅꯀꯄꯥ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯗꯤꯄꯥꯔꯇꯃꯦꯟꯇ (ETU) ꯗꯥ ꯆꯠꯄꯤꯌꯨ꯫

ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ꯫

ꯍꯤꯗꯥꯛ ꯑꯃꯍꯦꯛꯇꯒꯨꯝꯅꯥ ꯏꯄꯤꯂꯤꯃꯨꯃꯕꯅꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯈꯔꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯃꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯈꯔꯗꯤ ꯈꯨꯗꯛꯇꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯒꯗꯕꯅꯤ, ꯑꯗꯨꯒꯥ ꯑꯇꯩ ꯈꯔꯗꯤ ꯑꯁꯨꯛ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯣꯏꯗꯦ꯫ ꯃꯈꯥꯒꯤ ꯇꯦꯕꯜ ꯑꯁꯤꯗꯒꯤ ꯃꯁꯤ ꯃꯌꯦꯛ ꯁꯦꯡꯅꯥ ꯈꯉꯁꯤ꯫

ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ꯫ ꯃꯁꯛ ꯈꯪꯗꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫
ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯍꯥꯌꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫
ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯅꯁꯤꯡ꯫ ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯥꯌ, ꯊꯕꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ, ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ꯫
ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯗꯥꯏꯔꯤꯌꯥ ꯂꯩꯕꯥ꯫ ꯁꯥꯊꯤꯅꯥ ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯂꯨꯝꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯏ ꯊꯣꯀꯄꯥ, ꯑꯃꯁꯨꯡ ꯕ꯭ꯂꯦꯛ, ꯇꯦꯔꯤ ꯁ꯭ꯇꯣꯂꯁꯤꯡ꯫
ꯂꯤꯚꯔꯗꯥ ꯑꯃꯥꯡ-ꯑꯇꯥ ꯊꯣꯀꯍꯅꯕꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫ ꯃꯤꯠ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯌꯦꯔꯨꯝ ꯀꯣꯀꯄꯥ, ꯃꯌꯦꯛ ꯁꯦꯡꯕꯥ ꯌꯦꯔꯨꯝ/ ꯕ꯭ꯔꯎꯟ ꯌꯨꯔꯤꯟ, ꯂꯦꯡ-ꯑꯣꯠꯄꯒꯤ ꯃꯑꯣꯡ-ꯃꯇꯧ, ꯈꯣꯡꯒꯤ ꯃꯊꯛ ꯊꯪꯕꯥ ꯁꯔꯨꯛꯇꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯄꯥ, ꯆꯥꯛ ꯆꯥꯕꯥ ꯋꯥꯠꯄꯥ, ꯋꯥꯈꯜ ꯆꯔꯥꯡꯅꯕꯥ, ꯌꯥꯝꯅꯥ ꯋꯥꯅꯥ ꯋꯥꯈꯜ ꯇꯥꯕꯥ꯫
ꯈꯣꯡꯒꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡ꯫ ꯈꯣꯡꯗꯥ ꯂꯥꯎꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ (ꯃꯤꯠꯀꯤ ꯃꯅꯨꯡꯗꯥ ꯐꯥꯎꯕꯥ)꯫
ꯅꯔꯚ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡ꯫ ꯃꯈꯨꯠ-ꯃꯁꯥꯗꯥ ꯁꯣꯟꯊꯕꯥ, ꯑꯅꯥꯕꯥ, ꯃꯤꯠ ꯎꯗꯕꯥ, ꯃꯤꯠ ꯎꯗꯕꯥ, ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯅꯥ ꯃꯤꯠ ꯎꯗꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯁꯥ ꯃꯊꯟꯇꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ꯫
ꯍꯥꯔꯠ ꯔꯦꯇꯇꯥ ꯑꯍꯣꯡꯕꯥ ꯂꯥꯀꯄꯥ꯫ ꯅꯍꯥꯛꯀꯤ ꯊꯝꯃꯣꯌꯅꯥ ꯌꯥꯡꯅꯥ ꯅꯠꯠꯔꯒꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯁꯣꯀꯄꯥ, ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯈꯣꯌꯅꯥ ꯂꯦꯞꯄꯥ ꯂꯩꯇꯅꯥ ꯅꯠꯠꯔꯒꯥ ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯐꯥꯎꯔꯕꯗꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯍꯥꯌꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫
ꯀꯣꯛ ꯆꯤꯛꯄ ꯖꯦꯅꯦꯔꯦꯜ ꯍꯦꯗ-ꯑꯦꯛ꯫
ꯆꯥꯅꯤꯡꯕ ꯊꯛꯅꯤꯡꯕ ꯐꯥꯎꯕ ꯆꯥꯛ ꯆꯥꯕꯥ ꯍꯟꯊꯔꯀꯄꯥ꯫
ꯇꯨꯝꯕ ꯌꯥꯗꯕꯑꯌꯨꯛꯇꯥ ꯇꯨꯝꯕꯥ ꯉꯃꯗꯕꯥ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯂꯤꯁ꯭ꯠ ꯑꯁꯤꯗꯥ ꯄꯅꯈ꯭ꯔꯤꯕꯥ ꯑꯇꯩ ꯑꯆꯝꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯂꯩꯔꯕꯗꯤ, ꯆꯥꯅꯕꯤꯗꯨꯅꯥ ꯃꯈꯣꯌꯒꯤ ꯃꯇꯥꯡꯗꯁꯨ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫

ꯇꯦꯛ-ꯍꯣꯝ ꯃꯦꯁꯦꯖ ꯇꯧꯕꯥ꯫

  • ꯏꯄꯤꯂꯤꯃꯨꯃꯕ ꯑꯁꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯃꯁꯥꯒꯤ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯃꯅꯥ ꯀꯦꯟꯁꯔ ꯁꯦꯂꯁꯤꯡꯗꯥ ꯑꯦꯇꯦꯛ ꯇꯧꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯂꯤꯕꯥ ꯑꯀꯛꯅꯕꯥ ꯂꯥꯌꯦꯡ ꯑꯃꯅꯤ꯫
  • ꯂꯥꯏꯌꯦꯡ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯃꯦꯗꯤꯀꯦꯜ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯁꯨꯡ ꯑꯦꯂꯥꯔꯖꯤ ꯄꯨꯝꯅꯃꯛꯀꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯑꯁꯤ ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯃꯇꯃꯗꯥ ꯑꯃꯁꯨꯡ ꯃꯗꯨ ꯂꯣꯌꯔꯕꯥ ꯃꯇꯨꯡ ꯊꯥ 3 ꯐꯥꯎꯕꯥ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯊꯤꯡꯖꯤꯜꯂꯨ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯗꯥꯏꯔꯤꯌꯥ, ꯁꯥꯊꯤꯕꯥ ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯤꯠ ꯎꯗꯕꯥ, ꯅꯠꯠꯔꯒꯥ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ ꯑꯁꯤꯅꯆꯤꯡꯕꯥ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯑꯃꯠꯇꯥ ꯂꯩꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
  • ꯁꯦꯗ꯭ꯌꯨꯜ ꯇꯧꯔꯕꯥ ꯂꯥꯏꯌꯦꯡꯒꯤ ꯑꯦꯄꯣꯏꯟꯇꯃꯦꯟꯇꯁꯤꯡ ꯑꯗꯨ ꯊꯥꯗꯣꯛꯂꯣꯏꯗꯕꯅꯤ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯔꯝ ꯑꯃꯍꯦꯛꯇꯗꯒꯤ ꯅꯍꯥꯛꯅꯥ ꯂꯥꯀꯄꯥ ꯉꯃꯗ꯭ꯔꯕꯗꯤ, ꯆꯥꯅꯕꯤꯗꯨꯅꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯍꯥꯟꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫

ꯏꯄꯤꯂꯤꯃꯨꯃꯕ, ꯌꯦꯔꯚꯣꯌ, ꯀꯦꯟꯁꯔ, ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡ, ꯃꯣꯅꯣꯛꯂꯣꯅꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤ, ꯏꯝꯝꯌꯨꯅꯣꯊꯦꯔꯥꯄꯤ, ꯀꯦꯟꯁꯔꯒꯤ ꯍꯤꯗꯥꯛ, ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ꯫
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No comments yet. Be the first to share your thoughts here.

Add Your Comment

Please calculate: 2 + 6 =